Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
Nominees bring depth and diversity of scientific, commercial and financial experience to BoardNEW YORK and DURHAM, N.C., Aug. 13, 2021...
Month: August 2021
ContraFect Reports Second Quarter 2021 Financial Results and Provides Business Update
Multiple peer-reviewed journal publications and presentations at scientific forums drive value and recognition across the Company’s DLA portfolio Continued patient...
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused...
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
Strengthened the Company’s balance sheet by completing the business combination with Therapeutics Acquisition Corp (“RACA”), with gross proceeds from the...
Venus Concept Announces Second Quarter 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Bio-Path Holdings Reports Second Quarter 2021 Financial Results
Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH),...
Iterum Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
--Type A meeting with FDA expected late Q3 to define pathway to potential approval for Oral Sulopenem following July’s Complete...
Medicenna Reports First Quarter Fiscal 2022 Financial Results and Operational Highlights
-- Phase 1/2 ABILITY Study of MDNA11 in patients with advanced solid tumors remains on track for initiation in the...
Akero Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for...
23andMe Reports FY2022 First Quarter Financial Results
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance therapeutics portfolio to drive future...
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Longeveron to hold conference call today at 8:00 AM EDTMIAMI, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN)...
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies...
Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty
-- Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-response in six-minute walk test (6MWT)...
Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Quarter 2021 Financial Results on Monday, August 16
Guidance across all programs remains unchanged for expected data and clinical development milestones in 2021LONDON, Aug. 13, 2021 (GLOBE NEWSWIRE)...
HEXO to transfer U.S. stock exchange listing to Nasdaq
OTTAWA, Aug. 13, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today it...
CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission CMC and Non-Clinical Sections Will...
Announcement on mandatory share repurchase
In relation to the previously announced JSC AB CITY mandatory repurchase of JSC Olainfarm shares, Financial and Capital Market Commission has published the...
Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy
VANCOUVER, British Columbia, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2021 (UNAUDITED)
Company announcement, Inside Information, Helsinki, 13 August 2021 at 09:00 am (EEST) NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30...
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2021
Message from the CEO As is well known, IBT is conducting a large phase III study ("The Connection Study"), the...
